相关实验视频

Updated: Jul 19, 2026

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
08:44

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

8.1K

探索针对Hsp110作为新疗法的小分子抑制剂

Rui Zhao1, Congke Zhao2, Ruizhe Gao3

  • 1Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Hunan Normal University, Changsha 410013, Hunan, China; Shangdong Xin Zhonglu Hospital of Traditional Chinese Medicine, Jinan 250013, Shandong, China.

Drug discovery today
|January 5, 2025
PubMed
概括

热冲击蛋白 (HSP) 110,对于细胞平衡至关重要,是一个有前途的药物标. 新型疗法,特别是蛋白质-蛋白质相互作用抑制剂,显示出治疗与Hsp110相关的疾病的潜力.

关键词:
热冲击蛋白质 110 110 热冲击蛋白质是什么分子陪伴者分子陪伴者新奇的治疗方法.蛋白质蛋白质相互作用小分子抑制剂 小分子抑制剂

更多相关视频

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

2.7K
Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

5.1K

相关概念视频

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...